Md. Siam Hossain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Md. Siam Hossain has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mamun Or Rashid
Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
3 shared publications - Md. Monir Hossain
Jagannath University
2 shared publications - Monirul Islam
Department of Biochemistry and Molecular Biology, Noakhali Science and Technology University, Noakhali, Bangladesh
2 shared publications Abu Baker Seddique
1 shared publication- Fahad Hussain
Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
1 shared publication - Imren Bayıl
Department of Bioinformatics and Computational Biology, Gaziantep University, Gaziantep, Turkey
1 shared publication
Latest Publications
- 8 August 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 202, 95-106
Attenuation of morphine-induced memory deficits by Celosia cristata flower extract: Behavioral and computational insights
- 8 August 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 202, 95-106
Attenuation of morphine-induced memory deficits by Celosia cristata flower extract: Behavioral and computational insights
- 11 January 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (1) , 275-295
Phytochemical screening, psychopharmacological and memory-cognitive potentiality of the Stephania japonica methanolic extract: In vivo and in silico approaches
Stephania japonica is a traditional medicinal plant, possesses many pharmacological activities which are reported already; however, the neuropharmacological efficacy is still unclear. Considering this, our study was designed to investigate the neurobehavioral, spatial learning-memory, and motor learning efficacies of the methanolic extract of S. japonica (MSJ) on mice. Phytochemical screening was performed through GC-MS analysis. Anxiolytic efficacy of MSJ was investigated through open field, hole cross, elevated plus maze, and hole board tests separately; whereas antidepressant efficacy was assessed using forced swim and tail suspension tests. Spatial learning and memory, and motor learning efficacies of the mice were investigated through Morris water maze test (MWMT) and single palate reaching task (SPRT) respectively. A dose-dependent significant anxiolytic and antidepressant efficacies (p
- 11 January 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (1) , 275-295
Phytochemical screening, psychopharmacological and memory-cognitive potentiality of the Stephania japonica methanolic extract: In vivo and in silico approaches
Stephania japonica is a traditional medicinal plant, possesses many pharmacological activities which are reported already; however, the neuropharmacological efficacy is still unclear. Considering this, our study was designed to investigate the neurobehavioral, spatial learning-memory, and motor learning efficacies of the methanolic extract of S. japonica (MSJ) on mice. Phytochemical screening was performed through GC-MS analysis. Anxiolytic efficacy of MSJ was investigated through open field, hole cross, elevated plus maze, and hole board tests separately; whereas antidepressant efficacy was assessed using forced swim and tail suspension tests. Spatial learning and memory, and motor learning efficacies of the mice were investigated through Morris water maze test (MWMT) and single palate reaching task (SPRT) respectively. A dose-dependent significant anxiolytic and antidepressant efficacies (p
- RetractedOpen Access
- 17 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0311401
Structure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer’s disease treatment
In recent decades, Alzheimer’s disease (AD) has garnered significant attention due to its rapid global prevalence. The cholinergic hypothesis posits that the degradation of acetylcholine by acetylcholinesterase (AChE) contributes to AD development. Despite existing anti-AChE drugs, their adverse side effects necessitate new agents. This study analyzed 150 bioactive phytochemicals from Trachyspermum ammi using structure-based drug design and various in-silico tools to identify potent anti-AChE compounds. Compounds were screened for drug-likeness (QEDw ≥50%) and bioavailability (≥55%) and underwent toxicity profiling via the ProTox-II server. Selected compounds were prepared for molecular docking with the human AChE protein as the receptor. Viridifloral, 2-Methyl-3-glucosyloxy-5-isopropyl phenol, Alpha-Curcumene, and Sterol emerged as top candidates with high AChE affinity. These results were validated by molecular dynamics simulations, confirming stable interactions. The hit compounds were further evaluated for drug-likeness using Lipinski’s rule and ADMET properties, confirming favorable pharmacokinetic profiles. DFT optimization analyzed frontier molecular orbitals and electrostatic potential, demonstrating favorable chemical reactivity and stability. This study suggests that these identified compounds could be novel nature-derived AChE inhibitors, potentially contributing to AD treatment. However, further in-vitro and in-vivo studies are necessary to confirm their efficacy in biological systems. Future research will focus on developing these compounds into safe and effective drugs to combat Alzheimer’s disease.
- 17 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0311401
RetractedOpen AccessStructure-based virtual screening of Trachyspermum ammi metabolites targeting acetylcholinesterase for Alzheimer’s disease treatment
In recent decades, Alzheimer’s disease (AD) has garnered significant attention due to its rapid global prevalence. The cholinergic hypothesis posits that the degradation of acetylcholine by acetylcholinesterase (AChE) contributes to AD development. Despite existing anti-AChE drugs, their adverse side effects necessitate new agents. This study analyzed 150 bioactive phytochemicals from Trachyspermum ammi using structure-based drug design and various in-silico tools to identify potent anti-AChE compounds. Compounds were screened for drug-likeness (QEDw ≥50%) and bioavailability (≥55%) and underwent toxicity profiling via the ProTox-II server. Selected compounds were prepared for molecular docking with the human AChE protein as the receptor. Viridifloral, 2-Methyl-3-glucosyloxy-5-isopropyl phenol, Alpha-Curcumene, and Sterol emerged as top candidates with high AChE affinity. These results were validated by molecular dynamics simulations, confirming stable interactions. The hit compounds were further evaluated for drug-likeness using Lipinski’s rule and ADMET properties, confirming favorable pharmacokinetic profiles. DFT optimization analyzed frontier molecular orbitals and electrostatic potential, demonstrating favorable chemical reactivity and stability. This study suggests that these identified compounds could be novel nature-derived AChE inhibitors, potentially contributing to AD treatment. However, further in-vitro and in-vivo studies are necessary to confirm their efficacy in biological systems. Future research will focus on developing these compounds into safe and effective drugs to combat Alzheimer’s disease.